Covered recipient · General Payments record
FRANCESCO CALIFANO
Allopathic & Osteopathic Physicians Internal Medicine Critical Care Medicine
General Payments · PY2018–2024
$1,077.99
- Reported across 41 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $440.57 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $179.65 | 10 |
| Shionogi Inc | $112.31 | 1 |
| ABIOMED | $66.45 | 2 |
| CHIESI USA, INC. | $48.16 | 3 |
| Acerta Pharma LLC | $17.00 | 1 |
| PFIZER INC. | $17.00 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $17.71 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103405215 | CMS |
| ABBVIE INC. | $17.00 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103405217 | CMS |
| ABBVIE INC. | $17.70 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103405219 | CMS |
| ABBVIE INC. | $17.71 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103405221 | CMS |
| ABBVIE INC. | $17.71 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103405223 | CMS |
| ABBVIE INC. | $17.00 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103405225 | CMS |
| ABBVIE INC. | $18.48 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103405227 | CMS |
| ABBVIE INC. | $19.00 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103405229 | CMS |
| ABBVIE INC. | $18.34 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103405231 | CMS |
| ABBVIE INC. | $19.00 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103405233 | CMS |
| ABIOMED | $31.55 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142223240 | CMS |
| ABIOMED | $34.90 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142223242 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.00 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105448415 | CMS |
| Chiesi USA, Inc. | $16.98 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151802500 | CMS |
| Chiesi USA, Inc. | $16.45 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151802504 | CMS |
| Chiesi USA, Inc. | $14.73 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151802509 | CMS |
| PFIZER INC. | $17.00 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131732638 | CMS |
| Shionogi Inc | $112.31 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154341680 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.